The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.

The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.

Item
http://www.wikidata.org/entity/Q34729437
HSV-TK/GCV cancer suicide gene therapy by a designed recombinant multifunctional vector.Considering Fas ligand as a target for therapy.Doxorubicin generates a proapoptotic phenotype by phosphorylation of elongation factor 2.Gene therapy and immunotherapy of prostate cancer: adenoviral-based strategies.The present and future for gene and viral therapy of directly accessible prostate and squamous cell cancers of the head and neck.Gene therapy vector design strategies for the treatment of cancer.Finding the place of histone deacetylase inhibitors in prostate cancer therapy.Improved nonviral cancer suicide gene therapy using survivin promoter-driven mutant Bax.Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context.Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity.Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL.Two-step amplification of the human PPT sequence provides specific gene expression in an immunocompetent murine prostate cancer model.Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis.
P2860

The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.

Item
http://www.wikidata.org/entity/Q34729437
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.
@ast
The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.
@en
The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.
@nl
type
label
The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.
@ast
The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.
@en
The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.
@nl
prefLabel
The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.
@ast
The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.
@en
The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921